TWI255712B - Compound for inhibiting B type hepatitis antigen and its medicinal or food composition - Google Patents

Compound for inhibiting B type hepatitis antigen and its medicinal or food composition

Info

Publication number
TWI255712B
TWI255712B TW93113387A TW93113387A TWI255712B TW I255712 B TWI255712 B TW I255712B TW 93113387 A TW93113387 A TW 93113387A TW 93113387 A TW93113387 A TW 93113387A TW I255712 B TWI255712 B TW I255712B
Authority
TW
Taiwan
Prior art keywords
compound
medicinal
inhibiting
type hepatitis
food composition
Prior art date
Application number
TW93113387A
Other languages
Chinese (zh)
Other versions
TW200536531A (en
Inventor
Jing-Chu Chen
Ching-Nung Chen
Sheng-Jie Shiu
Original Assignee
Grape King Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grape King Inc filed Critical Grape King Inc
Priority to TW93113387A priority Critical patent/TWI255712B/en
Publication of TW200536531A publication Critical patent/TW200536531A/en
Application granted granted Critical
Publication of TWI255712B publication Critical patent/TWI255712B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Provided is a novel compound, antropyrroledione, which is isolated from Antrodia camphorota CCRC-35396. Its chemical structure is decided by analysis of the spectrum and X-ray scattering. Such a compound can effectively inhibit the expression of B type hepatitis surface antigen (HbsAg) and e antigen (HbeAg) under the non-cytotoxic concentration of 50 micro M. The inhibition rates are respectively reaching 35.2% and 12.8%.
TW93113387A 2004-05-13 2004-05-13 Compound for inhibiting B type hepatitis antigen and its medicinal or food composition TWI255712B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW93113387A TWI255712B (en) 2004-05-13 2004-05-13 Compound for inhibiting B type hepatitis antigen and its medicinal or food composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW93113387A TWI255712B (en) 2004-05-13 2004-05-13 Compound for inhibiting B type hepatitis antigen and its medicinal or food composition

Publications (2)

Publication Number Publication Date
TW200536531A TW200536531A (en) 2005-11-16
TWI255712B true TWI255712B (en) 2006-06-01

Family

ID=37613946

Family Applications (1)

Application Number Title Priority Date Filing Date
TW93113387A TWI255712B (en) 2004-05-13 2004-05-13 Compound for inhibiting B type hepatitis antigen and its medicinal or food composition

Country Status (1)

Country Link
TW (1) TWI255712B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022523521A (en) * 2019-02-25 2022-04-25 アージル・バイオテック・ホールディング・カンパニー・リミテッド Methods and compositions for inhibiting viral infection

Also Published As

Publication number Publication date
TW200536531A (en) 2005-11-16

Similar Documents

Publication Publication Date Title
WO2004018478A3 (en) Synthesis of epothilones, intermediates thereto, analogues and uses thereof
ATE367088T1 (en) FUNGICIDAL COMPOSITION CONTAINING A PYRIDYLETHYLBENZAMIDE DERIVATIVE AND A COMPOUND CAPABILITY OF INHIBITING ERGOSTEROL BIOSYNTHESIS
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
HK1113352A1 (en) Chemical compounds
HK1114375A1 (en) Chemical compounds
MXPA03011681A (en) Methods of using soluble epoxide hydrolase inhibitors.
JO3360B1 (en) New Crystalline From III of Agomelatine, A process for It's preparation and Pharmaceutical compositions Containing it.
TW200600971A (en) Calixresorcinarene compounds, photoresist base materials, and compositions thereof
WO2006115509A3 (en) Small molecule immunopotentiators and assays for their detection
HK1085675A1 (en) Anticancer compounds
EP2402321A3 (en) Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
NO20064344L (en) Caspase Inhibitors and Uses thereof
TW200745039A (en) Isotopically substituted pantoprazole
DE602004031410D1 (en) INDIVIDUAL DERIVATIVES AS PHARMACEUTICALS
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
TWI255712B (en) Compound for inhibiting B type hepatitis antigen and its medicinal or food composition
WO2003022844A3 (en) Synthesis of epothilones intermediates thereto and analogues thereof
WO2005054172A3 (en) Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof
GEP20084503B (en) New phenylpyridinylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
NO20044466L (en) Plasma carboxypeptidase B inhibitors
TW200643000A (en) Reaction product of resorcin and methyl ethyl ketone
GB0127568D0 (en) Chemical compounds
TW200738814A (en) ABS moulding materials containing special metal compounds
NO20071439L (en) Phenanthridine carbonyl phenols as cytokine modulators